Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Suspended × ABTL0812 × Clear all

Phase

Status

Suspended 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Drug Therapy 3 pembrolizumab 2 Vincristine 2 Temozolomide 2 S 1 (combination) 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Gemcitabine 2 Cyclophosphamide 2 Carboplatin 2 CA-4948 2 Bevacizumab 2 zimberelimab 1 venetoclax 1 tivozanib 1 titanium silicide 1 tisagenlecleucel 1 sotigalimab 1 selinexor 1 prednylidene 1 pimonidazole 1 palbociclib 1 imisopasem manganese 1 iberdomide 1 gusacitinib 1 gallium 68 PSMA-11 1 fludarabine 1 deltacortene 1 cabazitaxel 1 brincidofovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03417921 2025-10-01

Pancreatic

Ability Pharmaceuticals SL

Phase 1/2 Suspended

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡